blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3912624

EP3912624 - COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  23.11.2021
Database last updated on 03.09.2024
FormerThe application has been published
Status updated on  22.10.2021
Most recent event   Tooltip23.11.2021Withdrawal of applicationpublished on 08.12.2021  [2021/49]
Applicant(s)For all designated states
Virtexx
115 Rue des Hetres
69400 Arnas / FR
[2021/47]
Inventor(s)01 / GARNIER, Patrice
30125 VENEZIA / IT
02 / SALOME, Marc
31320 MERVILLA / FR
03 / DANCHIN, Antoine
75003 PARIS / FR
 [2021/47]
Representative(s)Vial, Lionel, et al
Bardehle Pagenberg SPE SAS
SO Square Opéra
5, rue Boudreau
75009 Paris / FR
[2021/47]
Application number, filing date20175287.018.05.2020
[2021/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3912624
Date:24.11.2021
Language:EN
[2021/47]
Search report(s)(Supplementary) European search report - dispatched on:EP22.10.2020
ClassificationIPC:A61K31/397, A61K31/4706, A61K31/7052, A61K31/706, A61P31/14
[2021/47]
CPC:
A61P31/14 (EP); A61K31/397 (EP); A61K31/4706 (EP);
A61K31/7052 (EP); A61K31/706 (EP)
C-Set:
A61K31/397, A61K2300/00 (EP);
A61K31/4706, A61K2300/00 (EP);
A61K31/7052, A61K2300/00 (EP);
A61K31/706, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/47]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON UMHÜLLTEN VIRENINFEKTIONEN[2021/47]
English:COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS[2021/47]
French:COMPOSÉS ET PROCÉDÉS POUR LE TRAITEMENT D'INFECTIONS DUES À DES VIRUS À ENVELOPPE[2021/47]
Examination procedure29.10.2021Application withdrawn by applicant  [2021/49]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2010027951  (UNIV ILLINOIS [US], et al) [X] 1,7,9,13,15 * paragraphs [0060] , [0063]; example 5; claims 4,7,8,12,18 *;
 [X]GB2562691  (REHAB ALJAMAL NAYLOR [GB], et al) [X] 1,7,9,13,15 * page 6, lines 6-27 * * page 7, paragraph 1; example 1 * * page 22, lines 22-25 * * page 23, lines 13,14 *;
 [X]  - ALEKSANDR IANEVSKI ET AL, "Novel activities of safe-in-human broad-spectrum antiviral agents", ANTIVIRAL RESEARCH, NL, (20180601), vol. 154, doi:10.1016/j.antiviral.2018.04.016, ISSN 0166-3542, pages 174 - 182, XP055641662 [X] 1,9 * See section 3.2; page 179, column 2, paragraph 2; table 1 *

DOI:   http://dx.doi.org/10.1016/j.antiviral.2018.04.016
 [X]  - OSUNA-RAMOS JUAN FIDEL ET AL, "Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, (20181101), vol. 160, doi:10.1016/J.ANTIVIRAL.2018.10.024, ISSN 0166-3542, pages 151 - 164, XP085534508 [X] 1,9 * page 152, column 1, lines 2-5 * * page 157, column 1, lines 8-17 * * page 161, column 2, lines 11-16,24-30 *

DOI:   http://dx.doi.org/10.1016/j.antiviral.2018.10.024
 [I]  - Stephen Sturley ET AL, "Insights into the COVID-19 pandemic from a rare neurodegenerative disease", doi:10.31219/osf.io/92f3s, (20200325), URL: https://osf.io/92f3s, (20201013), XP055739605 [I] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.31219/osf.io/92f3s
 [I]  - MANLI WANG ET AL, "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", CELL RESEARCH, GB, CN, (20200204), doi:10.1038/s41422-020-0282-0, ISSN 1001-0602, XP055672526 [I] 14 * last paragraph *

DOI:   http://dx.doi.org/10.1038/s41422-020-0282-0
by applicant   - FUK-WOO CHAN et al., Emerging Microbes & Infections, (20200000), vol. 9, pages 221 - 236
    - WANG et al., Cell Research, (20200000), vol. 30, pages 269 - 271
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.